论文部分内容阅读
目的:观察醒脑静注射液对女性脑梗死急性期治疗的影响。方法:选取2013年1月至2016年3月广州医科大学附属第三医院60例女性脑梗死患者,随机分为治疗组30例和对照组30例,记录患者临床资料及血液检测指标,对照组给予常规治疗,治疗组在对照组治疗的基础上给予醒脑静注射液,疗程均为10 d。治疗前、治疗后3 d、10 d进行神经功能缺损评分(NIHSS)。结果:两组治疗后3 d、10 d的NIHSS评分均较治疗前下降,差异具有统计学意义(P<0.05)。结论:醒脑静注射液对女性脑梗死急性期的治疗有一定的价值。
Objective: To observe the effects of xingnaojing injection on acute cerebral infarction in female patients. Methods: Sixty female patients with cerebral infarction from the Third Affiliated Hospital of Guangzhou Medical University from January 2013 to March 2016 were randomly divided into treatment group (n = 30) and control group (n = 30). The clinical data and blood test indices were recorded. The control group Given conventional treatment, the treatment group in the control group on the basis of treatment given Xingnaojing injection, treatment were 10 d. Neurological deficit scores (NIHSS) were measured before treatment and 3 days and 10 days after treatment. Results: The scores of NIHSS on the 3rd and 10th day after treatment in both groups were significantly lower than those before treatment (P <0.05). Conclusion: Xingnaojing Injection has certain value in the treatment of acute cerebral infarction in women.